We report the first case of recalcitrant diabetic wound treated successfully by twice-daily applications of a sterile fraction of human purified amniotic fluid (ViX001) obtained from thoroughly screened volunteers at the time of planned c-section at the term of normal pregnancies. Our product ViX001 was generated through a proprietary process and kept in frozen one milliliter (1 ml) vials (protein content was ~1mg/ml) thawed prior to applications (shelf life at 34oF of at least two weeks).
Keywords: Diabetic Foot Ulcer; Diabetic Wound; Exosomes; Extracellular Vesicles; Inflammation; Neoangiogenesis; Pain; Purified Amniotic Fluid; Regenerative Medicine; Tissue Repair; Wound Healing.